National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 21780 [2014-08680]

Download as PDF 21780 Federal Register / Vol. 79, No. 74 / Thursday, April 17, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Meeting TKELLEY on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Environmental Health Sciences Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Environmental Health Sciences Council. Date: May 13–14, 2014. Open: May 13, 2014, 8:30 a.m. to 5:00 p.m. Agenda: Discussion of program policies and issues. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Closed: May 14, 2014, 8:30 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Contact Person: Gwen W. Collman, Ph.D., Interim Director, Division of Extramural Research & Training, National Institutes of Health, Nat. Inst. of Environmental Health Sciences, 615 Davis Dr., KEY615/3112, Research Triangle Park, NC 27709, (919) 541– 4980, collman@niehs.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s Council home page: www.niehs.nih.gov/about/boards/naehsc/ index.cfm, where an agenda and any VerDate Mar<15>2010 17:28 Apr 16, 2014 Jkt 232001 additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS). Dated: April 11, 2014. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–08678 Filed 4–16–14; 8:45 am] BILLING CODE 4140–01–P Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: April 11, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–08680 Filed 4–16–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2014–0015] National Protection and Programs Directorate; Notice of Completion of Notification of Cyber-Dependent Infrastructure and Process for Requesting Reconsideration of Determinations of Cyber Criticality (Authority: E.O. 13636, 78 FR 11737) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) and Clinical Trial Planning Grants (R34). Date: May 12, 2014. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Quirijn Vos, Ph.D., Scientific Review Officer Scientific Review Program, Division of Extramural, Activities DHHS/NIH/NIAID, 6700B Rockledge Drive, MSC, 7616 Bethesda, MD 20892, 301–451– 2666, qvos@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 National Protection and Programs Directorate, DHS. ACTION: Public notice of completion of notification and process for requesting reconsideration to owners and operators of cyber-dependent infrastructure. AGENCY: The Secretary of Homeland Security has been directed to identify critical infrastructure where a cybersecurity incident could reasonably result in catastrophic regional or national effects on public health or safety, economic security, or national security. In addition to identifying such infrastructure, the Secretary has also been directed to confidentially notify owners and operators of critical infrastructure identified and establish a mechanism through which entities can request reconsideration of that identification, whether inclusion or exclusion from this list. This notice informs owners and operators of critical infrastructure that the confidential notification process is complete and describes the process for requesting reconsideration. DATES: The agency must receive the reconsideration package before May 15, 2014. ADDRESSES: Submit reconsideration requests and unclassified written reconsideration materials to CDII@ HQ.DHS.GOV. See SUPPLEMENTARY INFORMATION for formatting instructions. FOR FURTHER INFORMATION CONTACT: The Office of Cyber and Infrastructure Analysis, National Protection and Programs Directorate, United States Department of Homeland Security, Washington, DC 20528, or via email at cdii@hq.dhs.govmailto:carlos.kizzee@ dhs.gov. Responsible DHS Official: Under Secretary, National Protection and SUMMARY: E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 79, Number 74 (Thursday, April 17, 2014)]
[Notices]
[Page 21780]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08680]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement (U44) and Clinical Trial 
Planning Grants (R34).
    Date: May 12, 2014.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Quirijn Vos, Ph.D., Scientific Review Officer 
Scientific Review Program, Division of Extramural, Activities DHHS/
NIH/NIAID, 6700B Rockledge Drive, MSC, 7616 Bethesda, MD 20892, 301-
451-2666, qvos@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS).

    Dated: April 11, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-08680 Filed 4-16-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.